Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis

Internal Medicine

Volumn 44, Issue 12, 2006, Pages 1232-1238

  Kawamoto, Ryuichi ^a   Tomita, Hitomi ^a   Oka, Yuichiro ^a   Kodama, Akihiro ^a   Kamitani, Atsushi ^b  

^a Nomura Municipal Hospital   (Japan)

^b Kamitani Clinic   (Japan)

Author keywords

Atherosclerosis; LDL cholesterol; Lipid metabolism; Risk factor

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; B SCAN; BLOOD VESSEL PARAMETERS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; INTIMA MEDIA THICKNESS; JAPAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIPLE REGRESSION; OBESITY; PATHOGENESIS; RISK FACTOR; TUNICA MEDIA; VISCERA;

AGED; BIOLOGICAL MARKERS; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CHOLESTEROL, LDL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TUNICA INTIMA;

EID: 31444444241     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.1232     Document Type: Article

References (33)

1. Alberti KGMM, Zimmer PZ, for the WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 15: 539-553, 1998.
2. National Cholesterol Education Program: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
3. Kakeuchi H, Saitoh S, Takagi S, et al. Metabolic syndrome and insulin resistance in Japanese Male-Tanno-Soubetsu Study. J Japan Diab Soc 46: 739-744, 2003.
4. Shiwaku K, Nogi A, Kitajima K, et al. Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. J Occup Health 47: 126-135, 2005.
5. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 25: 1790-1794, 2002.
6. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288: 2709-2716, 2002.
7. Nakanishi N, Takatorige T, Fukuda H, et al. Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men. Diabetes Res Clin Pract 64: 59-70, 2004.
8. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28: 385-390, 2005.
9. Björntorp P. Abdominal obesity and the metabolic syndrome (Review). Ann Med 24: 465-468, 1992.
10. Yudkin JS. Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent? (Review) Diabetes Care 22 (Suppl. 3): C25-C30, 1999.
11. Okada M, Miida T, Hama H, et al. Possible risk factors of carotid artery atherosclerosis in the Japanese population: a primary prevention study in non-diabetic subjects. Intern Med 39: 362-368, 2000.
12. Tatsukawa M, Sawayama Y, Maeda N, et al. Carotid atherosclerosis and cardiovascular risk factors: a comparison of residents of a rural area of Okinawa with residents of a typical suburban area of Fukuoka, Japan. Atherosclerosis 172: 337-343, 2004.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1972.
14. Sidhu PS, Desai SR. A simple and reproducible method for assessing intima-media thickness of the common carotid artery. Br J Radiol 70: 85-89, 1997.
15. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 11: 1245-1249, 1991.
16. Suzuki R, Watanabe S, Hirai Y, et al. Abdominal wall fat index, estimated by ultrasonography, for assessment of the ratio of visceral fat to subcutaneous fat in the abdomen. Am J Med 95: 309-314, 1993.
17. Examination committee of criteria for diagnosis of metabolic syndrome in Japan. Definition and criteria for diagnosis of metabolic syndrome. J Jpn Soc Int Med 94: 794-809, 2005 (in Japanese, Abstract in English).
18. Tadokoro N. Ultrasonic diagnosis of visceral fat obesity. Nippon Rinsho 61: 374-379, 2003 (in Japanese, Abstract in English).
19. The examination Committee of Criteria for "Obesity Disease" in Japan, Japan Society for Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J 66: 987-992, 2002.
20. Kawamoto R, Doi T, Tokunaga H, Konishi I. An association between an antibody against Chlamydia pneumoniae and common carotid atherosclerosis. Intern Med 40: 208-213, 2001.
21. Kawamoto R, Kajiwara T, Oka Y, Takagi Y. Association between abdominal wall fat index and carotid atherosclerosis in women. J Atheroscler Thromb 9: 213-218, 2002.
22. Fujimoto WY, Bergstrom RW, Boyko EJ, et al. Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 22: 1808-1812, 1999.
23. Ohsuzu F, Takayama E, Hayashi K, et al. Relation of abdominal and thigh adipose tissue distribution to serum lipids and glucose metabolism in obese males. J Atheroscler Thromb 4: 34-39, 1997.
24. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24: 683-689, 2001.
25. Alexander CM, Landsman PB, Teutsch SM, Haffner SM; Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 52: 1210-1214. 2003.
26. Bonora E, Kiechl S, Willeit J, et al. Bruneck study: Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 26: 1251-1257, 2003.
27. Ogawa K, Ueda K. Sasaki H, et al. History of obesity as a risk factor for both carotid atherosclerosis and microangiopathy. Diabetes Res Clin Pract 66: S165-S168, 2004.
28. Scuteri A, Najjar SS, Muller DC, et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness, J Am Coll Cardiol 43: 1388-1395, 2004.
29. Hulthe J, Bokemark L, Wikstrand J, Fagerberg B. The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study. Arterioscler Thromb Vasc Biol 20: 2140-2147, 2000.
30. McNeill AM, Rosamond WD, Girman CJ, et al. Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). Am J Cardiol 94: 1249-1254, 2004.
31. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 92: 141-146, 1993.
32. Haffner SM, Mykkänen L, Robbins D, et al. A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia 38: 1328-1336, 1995.
33. Howard BV, Mayer-Davis EJ, Goff D, et al. Relationships between insulin resistance and lipoproteins in nondiabetic African Americans, Hispanics and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study. Metabolism 47: 1174-1179, 1998.